JP2023544615A5 - - Google Patents

Info

Publication number
JP2023544615A5
JP2023544615A5 JP2023521299A JP2023521299A JP2023544615A5 JP 2023544615 A5 JP2023544615 A5 JP 2023544615A5 JP 2023521299 A JP2023521299 A JP 2023521299A JP 2023521299 A JP2023521299 A JP 2023521299A JP 2023544615 A5 JP2023544615 A5 JP 2023544615A5
Authority
JP
Japan
Prior art keywords
alkyl
heteroatoms selected
membered
substituted
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023521299A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023544615A (ja
JP7823036B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/053937 external-priority patent/WO2022076663A1/en
Publication of JP2023544615A publication Critical patent/JP2023544615A/ja
Publication of JP2023544615A5 publication Critical patent/JP2023544615A5/ja
Application granted granted Critical
Publication of JP7823036B2 publication Critical patent/JP7823036B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023521299A 2020-10-07 2021-10-07 アセトアミド-フェニルテトラゾール誘導体およびその使用方法 Active JP7823036B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063088788P 2020-10-07 2020-10-07
US63/088,788 2020-10-07
PCT/US2021/053937 WO2022076663A1 (en) 2020-10-07 2021-10-07 Acetamido-phenyltetrazole derivatives and methods of using the same

Publications (3)

Publication Number Publication Date
JP2023544615A JP2023544615A (ja) 2023-10-24
JP2023544615A5 true JP2023544615A5 (https=) 2024-10-04
JP7823036B2 JP7823036B2 (ja) 2026-03-03

Family

ID=78483546

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023521299A Active JP7823036B2 (ja) 2020-10-07 2021-10-07 アセトアミド-フェニルテトラゾール誘導体およびその使用方法

Country Status (11)

Country Link
US (1) US11739089B2 (https=)
EP (1) EP4225747A1 (https=)
JP (1) JP7823036B2 (https=)
KR (1) KR20230104151A (https=)
CN (1) CN116964044B (https=)
AU (1) AU2021358074A1 (https=)
CA (1) CA3194694A1 (https=)
IL (1) IL301516A (https=)
MX (1) MX2023003933A (https=)
TW (1) TWI900672B (https=)
WO (1) WO2022076663A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10118890B2 (en) 2014-10-10 2018-11-06 The Research Foundation For The State University Of New York Trifluoromethoxylation of arenes via intramolecular trifluoromethoxy group migration
CN110312130B (zh) * 2019-06-25 2021-10-15 浙江大华技术股份有限公司 基于三角模式的帧间预测、视频编码方法及设备
TWI900672B (zh) 2020-10-07 2025-10-11 香港商希華醫藥有限公司 乙醯胺基-苯基四唑衍生物及其使用方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5663179A (en) 1992-07-10 1997-09-02 Laboratoires Glaxo Sa Certain isoquinoline derivatives having anti-tumor properties
US5763263A (en) 1995-11-27 1998-06-09 Dehlinger; Peter J. Method and apparatus for producing position addressable combinatorial libraries
GB9717576D0 (en) 1997-08-19 1997-10-22 Xenova Ltd Pharmaceutical compounds
KR100557093B1 (ko) * 2003-10-07 2006-03-03 한미약품 주식회사 다약제 내성 저해 활성을 갖는 테트라졸 유도체 및 그의제조방법
KR101466245B1 (ko) * 2010-01-15 2014-12-01 한미사이언스 주식회사 테트라졸 메탄설폰산 염의 제조방법 및 이에 사용되는 신규 화합물
KR101986683B1 (ko) 2012-12-13 2019-06-10 한미약품 주식회사 테트라졸 유도체를 활성 성분으로 포함하는 용해도가 개선된 고체 분산체
WO2015152433A1 (en) 2014-03-31 2015-10-08 Hanmi Pharm. Co., Ltd. Amorphous solid dispersion comprising paclitaxel, tablet comprising the same, and method for preparing the same
KR102293907B1 (ko) 2015-06-30 2021-08-26 한미약품 주식회사 이리노테칸 함유 경구용 고형제제 및 그 제조방법
TWI838700B (zh) 2015-09-30 2024-04-11 香港商慧源香港創新有限公司 口服紫杉烷組合物及方法
TWI833710B (zh) 2017-10-06 2024-03-01 香港商慧源香港創新有限公司 高單位含量口服型紫杉烷組合物及方法
TWI900672B (zh) 2020-10-07 2025-10-11 香港商希華醫藥有限公司 乙醯胺基-苯基四唑衍生物及其使用方法

Similar Documents

Publication Publication Date Title
JP2023544615A5 (https=)
JP2023536164A5 (https=)
JP2022520448A5 (https=)
JP2023537632A5 (https=)
JP2019094345A5 (https=)
JP2022520811A5 (https=)
JP2021534124A5 (https=)
JP2020521740A5 (https=)
WO2018013597A4 (en) 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors
JP2024501641A5 (https=)
JP2022544714A5 (https=)
JP2021529812A5 (https=)
RU2017145650A (ru) Ингибиторы тирозинкиназы брутона
JP2011509309A5 (https=)
JP2021500394A5 (https=)
JP2020521767A5 (https=)
JP2018505880A5 (https=)
TW201524964A (zh) 治療活性化合物及其使用方法(一)
JP2016538313A5 (https=)
JP2022501429A5 (https=)
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
JP2023531709A5 (https=)
JP2022511477A5 (https=)
JP2023533203A5 (https=)
RU2005131165A (ru) Производные имидазол-4-илэтинилпиридина